On April 29, Nephria Bio, a privately held US corporation specializing in the development of innovative approaches to dialysis, announced that it signed a license agreement with Drexel University to transfer technology of new MXene nanomaterials.

Read full article here: https://www.prnewswire.com/news-releases/nephria-bio-signs-exclusive-agreement-with-drexel-university-to-license-new-mxene-nanomaterial-for-future-dialysis-innovations-301279812.html